|

Baricitinib 4 MG Clinical Trials

1 actively recruiting trial

Also known as: Olumiant

Pipeline

Phase 4: 1

Top Sponsors

  • Chinese University of Hong Kong1

Indications

  • Arthritis1
  • Rheumatoid Arthritis1

Other1 trial

Effect of JAK Inhibitor on Erosion Healing in RA
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.